Henry Schein, Inc.
Henry Schein, Inc.
Your view on HSIC
Overview
What the company does, where it operates, and who runs it.
About Henry Schein, Inc.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Stanley M. Bergman CPA
- Headquarters
- 135 Duryea Road, Melville, NY, US
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Stanley M. Bergman CPA
- Headquarters
- 135 Duryea Road, Melville, NY, US
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.
This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins.
The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners.
This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Henry Schein, Inc. from FRC's valuation model, read against the market price. HSIC last traded at $84.96, 22.9× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Henry Schein, Inc.. Starting points for Henry Schein, Inc.: P/E 22.9, EPS $3.78, beta 0.86 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Henry Schein, Inc.. Henry Schein, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Henry Schein, Inc.. Trailing twelve-month EPS for Henry Schein, Inc. stands at $3.78. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$92.30
average of 10 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy8
- Hold4
- Sell1
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.41 | $1.43 | $5.48 | $6.01 |
| Low estimate | $1.40 | $1.39 | $5.31 | $5.86 |
| High estimate | $1.43 | $1.49 | $5.54 | $6.14 |
| No. of analysts | 8 | 9 | 7 | 11 |
| Year-ago EPS | $1.34 | $1.32 | $3.27 | — |
| Growth | +5.0% | +8.0% | +67.7% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $3.55B | $3.49B | $13.84B | $14.36B |
| Low estimate | $3.53B | $3.47B | $13.83B | $14.28B |
| High estimate | $3.56B | $3.53B | $13.86B | $14.49B |
| No. of analysts | 10 | 7 | 12 | 12 |
| Year-ago revenue | $3.44B | $3.37B | $13.18B | — |
| Growth | +3.2% | +3.5% | +5.0% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Henry Schein, Inc.. Henry Schein, Inc. has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- CAHCardinal Health, Inc.Medical - Distribution$65.6B
- CORCencora, Inc.Medical - Distribution$68.1B
- MCKMcKesson CorporationMedical - Distribution$127.6B
- NVSTEnvista Holdings CorpMedical - Instruments & Supplies$3.9B
- XRAYDENTSPLY SIRONA Inc.Medical - Instruments & Supplies$1.8B
More Medical - Distribution companies
- IUSDFAS ONE CorporationOTC$1.7B
- MAHLYMediPal Holdings CorporationOTC$4.2B
- MCICMultiCorp International, Inc.OTC$131,239
- MEDOFMedios AGOTC$1.2B
- MEPDFMediPal Holdings CorporationOTC$3.9B
- NSVGFNass Valley Gateway Ltd.OTC$3M
- PDRXPD-Rx Pharmaceuticals, Inc.OTC$6M
- PGC.AXParagon Care LimitedASX
- PHRXPharmagen, Inc.OTC$5,171
- RDGTRidgetech Inc.NASDAQ$4M
- SAEYYRedcare Pharmacy N.V.OTC$1.4B
ETFs holding Henry Schein, Inc.
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.01%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.01%
- RSPInvesco S&P 500 Equal Weight ETF$101.8B in assets0.19%
- VBVanguard Small-Cap ETF$76.9B in assets0.10%
- CWSAdvisorShares Focused Equity ETF$111M in assets4.48%
- FLVAmerican Century Focused Large Cap Value ETFAmerican Century Focused Large Cap Value ETFAmerican Century Focused Large Cap Value ETF$405M in assets1.58%
- XHSState Street SPDR S&P Health Care Services ETF$245M in assets1.56%
- FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets0.91%
Largest holders first, then the funds most concentrated in HSIC.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Henry Schein, Inc., and how their positions are changing. At a $9.39B market value, institutional positions materially move Henry Schein, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Henry Schein, Inc. executives and directors. Shares of Henry Schein, Inc. have traded between $60.56 and $82.49 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Henry Schein, Inc.. Henry Schein, Inc. is a $9.39B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Henry Schein, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Henry Schein, Inc.. Coverage tracks Henry Schein, Inc. within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Henry Schein, Inc.